Retatrutide Explained: The "Triple-G" Peptide

The next name after semaglutide and tirzepatide — what the research is exploring.

Published by Peptide Protocols · Reviewed September 2026 · How we make these pages · Educational & research purposes only — not medical advice.

Once you've heard of semaglutide (one pathway) and tirzepatide (two), the next name in the research conversation is retatrutide — nicknamed the "triple-G" because of how many receptor pathways it engages. Here's the plain-English version of what it is and how it fits.

Why it's called "triple-G"

Semaglutide = 1 pathway (GLP-1). Tirzepatide = 2 (GLP-1 + GIP). Retatrutide = 3 (GLP-1 + GIP + glucagon). Adding the glucagon-receptor pathway is the distinguishing feature people research about it.

That third pathway is why retatrutide is studied as a further "next-generation" step in the class rather than a repeat of what came before. If you want the two-way comparison first, start with tirzepatide vs semaglutide.

What the research explores

Important honesty: retatrutide is investigational — still working through the research/clinical process. That means less is settled, and it is not an approved medication. Treat everything about it as "what research is exploring," not established outcomes.

The catch is the same across the whole class

Retatrutide, tirzepatide, semaglutide — they share the class-wide catch: fast weight loss can take lean muscle along with fat. The more effective the appetite reduction, the more deliberate you have to be about protein and resistance training to hold onto muscle. This is the single most important thing to plan for on any compound in this family.

Protect your muscle on any GLP-1-class compound

Our GLP-1 Muscle-Preservation Guide applies across the class — protein targets, low-appetite eating, a no-gym strength plan, and fat-vs-muscle tracking, with an Excel tracker included.

Get the GLP-1 Muscle guide on Etsy →

Sourcing & the honest caution

Because retatrutide is investigational, the research-peptide market around it is especially unsettled — quality and legality vary widely, and hype runs ahead of evidence. If you're researching this space at all, the sourcing bar should be higher, not lower: published COAs matching the lot, purity ≥98%, research-use labeling, and a hard look at the 2026 legal status. Our supplier checklist covers what to demand.

Vet the supplier yourself

We do not recommend or partner with any peptide supplier. Use the checklist instead: third-party COAs that match your batch and lot, stated purity, clear research-use labeling, real support and proper cold-chain shipping.

The supplier checklist →

Educational content only. Confirm the legal status where you live before ordering anything.

Quick FAQ

Is retatrutide better than tirzepatide?

It's investigational, so "better" isn't established — the meaningful difference is the added glucagon pathway (three receptors vs. two). Don't treat hype as proof.

Is retatrutide approved?

No — it's an investigational compound still in the research/clinical pipeline as of 2026. See our FDA status guide.

Does it cause muscle loss too?

The whole class shares that risk. Protein + resistance training protect muscle — see the Muscle-Preservation guide.

Keep reading

Whatever comes next in the class — keep your muscle

The GLP-1 Muscle-Preservation guide gives you the nutrition-and-training playbook that applies to every compound in this family, plus an Excel tracker.

Browse the shop on Etsy →
Free · Instant · Plain-English
Get the free Reconstitution Cheat Sheet

The one formula, a BAC-water chart, and the 10 most-researched beginner peptides — the math done for you. Print it for the fridge.

🎁 Send me the free cheat sheet →

Related guides